This inventor holds 1 USPTO granted patent. Top assignee: Fudan University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jiucun Wang: Innovator in Human Immortalized B Lymphocyte Cell Lines
Introduction
Jiucun Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of human immortalized B lymphocyte cell lines. His work has implications for various applications in medical research and diagnostics.
Latest Patents
Jiucun Wang holds a patent titled "Establishment and application of human immortalized B lymphocyte cell line group." This patent provides a group of human immortalized B lymphocyte cell lines and their uses. Specifically, it offers a combination of four closely related immortalized lymphocyte cell lines. This combination can serve as reference substances for measuring the performance of detection platforms. When utilized as reference substances for epigenome, transcriptome, proteome, and metabolome studies, these cell lines can create an intrinsic magnitude difference gradient. This gradient is essential for evaluating the sensitivity of histological detection.
Career Highlights
Jiucun Wang is affiliated with Fudan University, where he continues to advance his research in cell biology and biotechnology. His innovative work has garnered attention in the scientific community, contributing to the understanding of immune responses and cellular behavior.
Collaborations
Some of his notable coworkers include Leming Shi and Wanwan Hou. Their collaborative efforts have further enhanced the research output and innovation in their respective fields.
Conclusion
Jiucun Wang's contributions to the development of human immortalized B lymphocyte cell lines represent a significant advancement in biotechnology. His work not only aids in research but also has the potential to improve diagnostic methods in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
